MENU
BRNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Barinthus Biotherapeutics (BRNS) Ownership - Who owns Barinthus Biotherapeutics?
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer... Show more
Profile
Industry
N/A
Address
Unit 6-10, Rutherford Avenue
Phone
+44 1865818808
Employees
98
Web
https://www.barinthusbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
55.67M
P/E Ratio
N/A
Total Cash
99.12M
Projected Growth
N/A
Total Debt
11.92M
Revenue
14.97M
Risk (Beta)
-1.20
Dividend Yield
N/A
Total Cash/Share
2.46
Total Debt/Equity
N/A
Revenue/Share
0.38 USD as % of share price
Fundamentals
BRNS
Capitalization
55.7M
P/E Ratio
N/A
Risk (Beta)
-1.20
Dividend Yield
N/A
Total Cash
99.1M
Total Cash/Share
2.46
Total Debt
11.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.38%
Revenue
15M
ROE
N/A
Book Value
115M
P/B Ratio
0.45
Cash Flow
N/A
Earnings
-1.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
9.18
Current Revenue Per Employee
115146.16
Dividends Per Share - Security
N/A
EBITDA
-58.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-38.21
Shares Held By Institutions
8.92M
Shares Outstanding - Current
40.3M
Total Liabilities
26.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
14.238
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Unit 6-10, Rutherford Avenue
Phone
+44 1865818808
Employees
98
Web
https://www.barinthusbio.com